Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Journal of the National Cancer Institute
|
May 17, 2019
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
Ching-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, et al.
Scientific Reports
|
January 30, 2020
Impact of deviation from guideline recommended treatment on breast cancer survival in Asia
Peh Joo Ho, Samuel Guan Wei Ow, Yirong Sim, et al.
World Journal of Clinical Oncology
|
July 31, 2020
Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience
Ga-Jing Kee, Ryan Ying-Cong Tan, Sultana Rehena, et al.
Plos One
|
July 8, 2014
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells
Bee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, et al.
Plos One
|
July 30, 2015
Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population
Edward S Y Wong, Sandhya Shekar, Claire H T Chan, et al.
The Lancet. Oncology
|
April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Fabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
Cancer Research and Treatment
|
June 6, 2019
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
Sung-Bae Kim, In-Gu Do, Janice Tsang, et al.
Plos One
|
September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform
Yoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Human Genomics
|
July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Ning-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
The New England Journal of Medicine
|
March 9, 2022
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
Gabriel N Hortobagyi, Salomon M Stemmer, Howard A Burris, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Journal of the National Cancer Institute
|
May 17, 2019
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
Ching-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, et al.
Scientific Reports
|
January 30, 2020
Impact of deviation from guideline recommended treatment on breast cancer survival in Asia
Peh Joo Ho, Samuel Guan Wei Ow, Yirong Sim, et al.
World Journal of Clinical Oncology
|
July 31, 2020
Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience
Ga-Jing Kee, Ryan Ying-Cong Tan, Sultana Rehena, et al.
Plos One
|
July 8, 2014
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells
Bee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, et al.
Plos One
|
July 30, 2015
Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population
Edward S Y Wong, Sandhya Shekar, Claire H T Chan, et al.
The Lancet. Oncology
|
April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Fabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
Cancer Research and Treatment
|
June 6, 2019
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
Sung-Bae Kim, In-Gu Do, Janice Tsang, et al.
Plos One
|
September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform
Yoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Human Genomics
|
July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Ning-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
The New England Journal of Medicine
|
March 9, 2022
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
Gabriel N Hortobagyi, Salomon M Stemmer, Howard A Burris, et al.
Page
of 10